Health care leads the way for top private AI firms
- Bryan Walsh, author of Axios Future

Illustration: Sarah Grillo/Axios
A new list of the top 100 private AI companies shows that health is driving investment in the industry.
Why it matters: COVID-19 has shown the power and potential of AI applications for health, and the growth of the field will continue long after the pandemic has finally ended.
What's happening: Wednesday morning, the business research firm CB Insights released its annual AI 100 ranking of the most promising private companies working in artificial intelligence.
- The list includes companies headquartered in 12 countries and nearly 20 different industries.
- The firms on the list have raised more than $11.7 billion in equity funding collectively since 2010, and 12 companies have a valuation over $1 billion.
What they're saying: "The list is a testament to not just the breadth of AI’s impact but also the depth of automation within industries," says Deepashri Varadharajan, lead analyst for emerging tech at CB Insights.
Details: AI companies focused on health care claimed the most spots on the list with eight, including some working on surgical technology, clinical trials and even dental insurance.
- Health care AI startups enjoyed record funding in the third quarter of 2020, with 122 deals adding up to more than $2 billion.
- "While health care has always been one of the top categories in the AI 100, the pandemic certainly accelerated AI's adoption in the space," says Varadharajan.
The bottom line: One of the biggest takeaways of the AI 100 ranking is the way artificial intelligence has moved from the digital realm into the physical world — and there's nothing more physical than our health.
Go deeper: Coronavirus accelerates AI in health care